Atlas Trials

Systemic Mastocytosis

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Systemic Mastocytosis

RecordFirmDate
Flotetuzumab for the Treatment of Relapsed or Refractory Advanced CD123-Positive Hematological Malignancies (NCT04681105)City of Hope Medical Center2020-11-18
Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer (NCT03739606)City of Hope Medical Center2020-10-20
GTB-3550 Tri-Specific Killer Engager (TriKE®) for High Risk Hematological Malignancies (NCT03214666)GT Biopharma, Inc.2020-01-01
Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis (NCT03401060)Assistance Publique - Hôpitaux de Paris2018-03-05
Diagnostic Value of Bone Marrow Tryptase in Systemic Mastocytosis (NCT02441166)University Hospital, Toulouse2015-10-06
Treatment of Indolent Systemic Mastocytosis With PA101 (NCT02478957)Patara Pharma2015-06-01
Ibrutinib in Treating Patients With Advanced Systemic Mastocytosis (NCT02415608)Jason Robert Gotlib2015-03-01
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis (NCT01602939)Hospital Virgen de la Salud2012-05-01
Imatinib in KIT-negative Systemic Mastocytosis (NCT01297777)Hospital Virgen de la Salud2011-01-01
Evaluation of Response of Dasatinib to Treat Mastocytosis (NCT00979160)Federico II University2009-11-01
Obatoclax for Systemic Mastocytosis (NCT00918931)M.D. Anderson Cancer Center2009-06-01
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis (NCT00449748)M.D. Anderson Cancer Center2007-04-01
Use of Tamoxifen in Systemic Mastocytosis (NCT01334996)Mayo Clinic2005-02-01
Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes (NCT00171912)Novartis Pharmaceuticals2004-09-01
Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM) (NCT00493129)M.D. Anderson Cancer Center2004-07-01

Track Systemic Mastocytosis automatically

Every clearance here is in the API, with alerts when new ones post.